12 Publikationen

Alle markieren

  • [12]
    2021 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2946327 OA
    Anselmi M, Borbély AN, Figueras Agustí E, et al. Linker Hydrophilicity Modulates the Anticancer Activity of RGD-Cryptophycin Conjugates. Chemistry - A European Journal . 2021;27(3):1015-1022.
    PUB | PDF | DOI | WoS | PubMed | Europe PMC
     
  • [11]
    2020 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2940382 OA
    Borbély AN, Thoreau F, Figueras Agustí E, et al. Synthesis and Biological Characterization of Monomeric and Tetrameric RGD-Cryptophycin Conjugates. Chemistry - A European Journal. 2020;26(12):2602-2605.
    PUB | PDF | DOI | WoS | PubMed | Europe PMC
     
  • [10]
    2019 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2936495 OA
    Borbély AN, Figueras Agustí E, Martins A, et al. Conjugates of Cryptophycin and RGD or isoDGR Peptidomimetics for Targeted Drug Delivery. ChemistryOpen. 2019;8(6):737-742.
    PUB | PDF | DOI | WoS | PubMed | Europe PMC
     
  • [9]
    2019 | Dissertation | PUB-ID: 2937966
    Borbély AN. Conjugates of Cryptophycin and RGD Peptides for Targeted Cancer Therapy. Bielefeld: Universität Bielefeld; 2019.
    PUB
     
  • [8]
    2019 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2934762 OA
    Borbély AN, Figueras Agustí E, Martins A, et al. Synthesis and Biological Evaluation of RGD–Cryptophycin Conjugates for Targeted Drug Delivery. Pharmaceutics. 2019;11(4): 151.
    PUB | PDF | DOI | WoS | PubMed | Europe PMC
     
  • [7]
    2019 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2935650 OA
    Figueras Agustí E, Martins A, Borbély AN, et al. Octreotide Conjugates for Tumor Targeting and Imaging. Pharmaceutics. 2019;11(5): 220.
    PUB | PDF | DOI | WoS | PubMed | Europe PMC
     
  • [6]
    2018 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2920953
    Figueras Agustí E, Borbély AN, Ismail M, Frese M, Sewald N. Novel unit B cryptophycin analogues as payloads for targeted therapy. Beilstein Journal of Organic Chemistry. 2018;14:1281-1286.
    PUB | DOI | WoS | PubMed | Europe PMC
     
  • [5]
    2018 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2932984 OA
    Cazzamalli S, Figueras Agustí E, Petho L, et al. In Vivo Antitumor Activity of a Novel Acetazolamide-Cryptophycin Conjugate for the Treatment of Renal Cell Carcinomas. ACS Omega. 2018;3(11):14726-14731.
    PUB | PDF | DOI | WoS | PubMed | Europe PMC
     
  • [4]
    2018 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2944897
    Cazzamalli S, Figueras Agustí E, Pethő L, et al. Correction: In Vivo Antitumor Activity of a Novel Acetazolamide–Cryptophycin Conjugate for the Treatment of Renal Cell Carcinoma. ACS Omega. 2018;3(12):16743-16743.
    PUB | DOI | WoS | PubMed | Europe PMC
     
  • [3]
    2018 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2931993
    Borbély AN, Figueras Agustí E, Martins A, et al. Novel Cryptophycin-based Conjugates for Tumor Targeting. In: JOURNAL OF PEPTIDE SCIENCE. Vol 24. Hoboken: Wiley; 2018: S59.
    PUB | WoS
     
  • [2]
    2018 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2931996
    Figueras Agustí E, Martins A, Borbély AN, et al. Tumor Targeting of Cryptophycin based Conjugates Using Octreotide as Delivery Vehicle. In: JOURNAL OF PEPTIDE SCIENCE. Vol 24. Hoboken: Wiley; 2018: S166.
    PUB | WoS
     
  • [1]
    2017 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2916981 OA
    Weiss C, Figueras Agustí E, Borbély AN, Sewald N. Cryptophycins: cytotoxic cyclodepsipeptides with potential for tumor targeting. Journal of Peptide Science. 2017;23(7-8):514-531.
    PUB | PDF | DOI | WoS | PubMed | Europe PMC
     

Suche

Publikationen filtern

Darstellung / Sortierung

Export / Einbettung